APPLIED DNA SCIENCES INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Applied Dna Sciences Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
Applied Dna Sciences Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.35M, a 17.1% decline year-over-year.
Applied Dna Sciences Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$14.9M, a 35.3% decline year-over-year.
Applied Dna Sciences Inc annual Operating Income (Loss) for 2023 was -$11M, a 21.6% increase from 2022.
Applied Dna Sciences Inc annual Operating Income (Loss) for 2022 was -$14M, a 4.65% decline from 2021.
Applied Dna Sciences Inc annual Operating Income (Loss) for 2021 was -$13.3M, a 6.49% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$14.9M	-$3.35M	-$488K	-17.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$14.4M	-$3.62M	-$914K	-33.8%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	-$13.5M	-$3.79M	-$2.57M	-211%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-08
Q3 2023	-$11M	-$4.17M	+$81.1K	+1.91%	Jul 1, 2023	Sep 30, 2023	10-K	2023-12-07
Q2 2023	-$11M	-$2.86M	-$2.47K	-0.09%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$11M	-$2.7M	-$550K	-25.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	-$10.5M	-$1.22M	+$3.49M	+74.1%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-08
Q3 2022	-$14M	-$4.25M	+$366K	+7.92%	Jul 1, 2022	Sep 30, 2022	10-K	2023-12-07
Q2 2022	-$14.3M	-$2.86M	+$585K	+17%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$14.9M	-$2.15M	+$162K	+6.98%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$15.1M	-$4.71M	-$1.73M	-58.3%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-02-09
Q3 2021	-$13.3M	-$4.62M	-$565K	-13.9%	Jul 1, 2021	Sep 30, 2021	10-K	2022-12-14
Q2 2021	-$12.8M	-$3.44M	-$253K	-7.93%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$12.5M	-$2.32M	+$366K	+13.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$12.9M	-$2.97M	-$362K	-13.9%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-10
Q3 2020	-$12.5M	-$4.05M	-$2.19M	-117%	Jul 1, 2020	Sep 30, 2020	10-K/A	2021-12-14
Q2 2020	-$10.3M	-$3.19M	-$1.76M	-123%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$8.59M	-$2.68M	-$49.6K	-1.88%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	-$8.54M	-$2.61M	+$585K	+18.3%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-02-11
Q3 2019	-$9.12M	-$1.86M	+$1.6M	+46.2%	Jul 1, 2019	Sep 30, 2019	10-K	2020-12-17
Q2 2019	-$10.7M	-$1.43M	+$1.43M	+50.1%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	-$12.2M	-$2.63M	-$493K	-23%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	-$11.7M	-$3.2M	-$21.5K	-0.68%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-02-06
Q3 2018	-$11.6M	-$3.47M	-$623K	-21.9%	Jul 1, 2018	Sep 30, 2018	10-K	2019-12-12
Q2 2018	-$11M	-$2.87M	-$264K	-10.1%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	-$10.8M	-$2.14M	+$1.28M	+37.5%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	-$12M	-$3.17M	+$779K	+19.7%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-07
Q3 2017	-$12.8M	-$2.84M	-$433K	-18%	Jul 1, 2017	Sep 30, 2017	10-K	2018-12-18
Q2 2017	-$12.4M	-$2.6M	+$820K	+24%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-13
Q1 2017	-$13.2M	-$3.42M	+$25.6K	+0.74%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-03
Q4 2016	-$13.2M	-$3.95M	-$1.03M	-35.4%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-02-08
Q3 2016	-$12.2M	-$2.41M	-$1.92M	-397%	Jul 1, 2016	Sep 30, 2016	10-K	2017-12-28
Q2 2016	-$10.3M	-$3.42M	-$1.75M	-105%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-10
Q1 2016	-$8.53M	-$3.45M	-$1.57M	-83.5%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-11
Q4 2015	-$6.96M	-$2.92M	+$897K	+23.5%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-09
Q3 2015	-$7.85M	-$485K	+$2.36M	+82.9%	Jul 1, 2015	Sep 30, 2015	10-K	2016-12-06
Q2 2015	-$10.2M	-$1.67M	+$815K	+32.8%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-11
Q1 2015	-$11M	-$1.88M	+$1.25M	+39.9%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-12
Q4 2014	-$12.3M	-$3.82M	-$4.96K	-0.13%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-10
Q3 2014	-$12.3M	-$2.84M	-$492K	-20.9%	Jul 1, 2014	Sep 30, 2014	10-K	2015-12-14
Q2 2014	-$11.8M	-$2.49M	+$356K	+12.5%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-10
Q1 2014	-$12.1M	-$3.13M	-$519K	-19.9%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-11
Q4 2013	-$11.6M	-$3.81M	-$1.44M	-60.7%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-02-09
Q3 2013	-$10.2M	-$2.35M	-$585K	-33.1%	Jul 1, 2013	Sep 30, 2013	10-K	2014-12-15
Q2 2013	-$9.59M	-$2.84M	-$1.42M	-99.2%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-11
Q1 2013	-$8.17M	-$2.61M	-$1.11M	-73.8%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-12
Q4 2012	-$7.07M	-$2.37M	-$560K	-30.9%	Oct 1, 2012	Dec 31, 2012	10-Q/A	2014-05-02
Q3 2012	-$6.51M	-$1.77M	+$2.01M	+53.2%	Jul 1, 2012	Sep 30, 2012	10-K	2014-12-15
Q2 2012	-$8.52M	-$1.43M	+$63.7K	+4.28%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-13
Q1 2012	-$8.58M	-$1.5M	+$163K	+9.78%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-15
Q4 2011	-$8.74M	-$1.81M	-$687K	-61.1%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-14
Q3 2011	-$8.06M	-$3.78M			Jul 1, 2011	Sep 30, 2011	10-K	2012-12-20
Q2 2011		-$1.49M	+$980K	+39.7%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-14
Q1 2011		-$1.66M			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-15
Q4 2010		-$1.12M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-14
Q2 2010		-$2.47M			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.